{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T16:10:13Z","timestamp":1742055013560,"version":"3.38.0"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T00:00:00Z","timestamp":1323648000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0028975","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T22:06:34Z","timestamp":1323727594000},"page":"e28975","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Autoantibodies against the Catalytic Domain of BRAF Are Not Specific Serum Markers for Rheumatoid Arthritis"],"prefix":"10.1371","volume":"6","author":[{"given":"Wenli","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shipeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lunan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,12,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10408360701295623","article-title":"Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts.","volume":"44","author":"A Raptopoulou","year":"2007","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/ard.2008.096917","article-title":"New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA.","volume":"68","author":"I Auger","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/MCB.19.4.2435","article-title":"Mitogen-activated protein kinase: specific messages from ubiquitous messengers.","volume":"19","author":"HJ Schaeffer","year":"1999","journal-title":"Mol Cell Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer.","volume":"417","author":"H Davies","year":"2002","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.5414\/CPP40580","article-title":"Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors.","volume":"40","author":"D Strumberg","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/art.25060","article-title":"Involvement of MAPKs and NF-kappaB in tumor necrosis factor alpha-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts.","volume":"62","author":"SF Luo","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/ard.2007.074278","article-title":"The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis.","volume":"67","author":"G Schett","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/rheumatology\/kem297","article-title":"MAPKs and their relevance to arthritis and inflammation.","volume":"47","author":"T Thalhamer","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002281-200405000-00011","article-title":"Signal transduction in rheumatoid arthritis.","volume":"16","author":"SE Sweeney","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/ar3165","article-title":"Autoantibodies to BRAF, a new family of autoantibodies associated with rheumatoid arthritis.","volume":"12","author":"C Charpin","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"FC Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10067-010-1671-4","article-title":"Predominance of IgG1 and IgG3 subclasses of autoantibodies to peptidylarginine deiminase 4 in rheumatoid arthritis.","volume":"30","author":"W Wang","year":"2011","journal-title":"Clin Rheumatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/IAI.64.9.3584-3591.1996","article-title":"Seroprevalence and specificity of human responses to the <italic>Plasmodium falciparum<\/italic> rhoptry protein Rhop-3 determined by using a C-terminal recombinant protein.","volume":"64","author":"JC Yang","year":"1996","journal-title":"Infect Immun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-9378-1-6","article-title":"Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins.","volume":"1","author":"P Di Bonito","year":"2006","journal-title":"Infect Agent Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1084\/jem.188.5.985","article-title":"Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus.","volume":"188","author":"HB Richards","year":"1998","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/35065000","article-title":"Mammalian MAP kinase signalling cascades.","volume":"410","author":"L Chang","year":"2001","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases.","volume":"107","author":"PP Tak","year":"2001","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"24832","DOI":"10.1074\/jbc.273.38.24832","article-title":"Regulation of interleukin-1\u03b2-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase.","volume":"273","author":"K Miyazawa","year":"1998","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF02238963","article-title":"Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins.","volume":"16","author":"JK Lacki","year":"1997","journal-title":"Clin Rheumatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/MCB.21.7.2373-2383.2001","article-title":"p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.","volume":"21","author":"J Westermarck","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2407-4-62","article-title":"B-Raf specific antibody responses in melanoma patients.","volume":"4","author":"J Fensterle","year":"2004","journal-title":"BMC Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.510240128","article-title":"Liver cell uptake and degradation of soluble immunoglobulin G immune complexes in vivo and in vitro in rats.","volume":"24","author":"AG Johansson","year":"1996","journal-title":"Hepatology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0028975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T15:53:05Z","timestamp":1742053985000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0028975"}},"subtitle":[],"editor":[{"given":"Mehrdad","family":"Matloubian","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,12]]},"references-count":22,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0028975","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2011,12,12]]}}}